BrandName_1603

Category- Allopathy

Medicine Highlights

Uses 1. To reduce pressure on eyes in glaucoma
Common Side Effects  1. Diarrhea 
2. Vomiting 
3. Loss of appetite 
4. Numbness or tingling in arms or legs 
5. Increased thirst 
6. Increased urination frequency 
7. Drowsiness 
8. Headache 
9. Change in taste/Metallic taste 
10. Decrease in sexual drive 
Additional Information 1. Do not touch the tip of the nozzle. 
2. Do not use the drops if you feel any irritation in eyes 
3. Do not use this medication if the seal is broken. 
Storage 1. The medicine should be stored at room temperature.
2. Keep away from sunlight and moisture.
3. Keep away from the reach of children
How to Take This MedicineInstill one or two drops into the eye pocket without touching the bottle tip.

BrandName Uses

BrandName is an eye drop medication belonging to the category of carbonic anhydrase inhibitors and is used for the following indications:

  1. Glaucoma
  2. High Blood Pressure in Eyes.

BrandName side effects 

More Common  

  1. Body aches or pain  
  2. Cough  
  3. Difficulty with breathing  
  4. Ear congestion  
  5. Loss of voice  
  6. Redness of the white part of eyes or inside of the eyelids  
  7. Sneezing  
  8. Sore throat  
  9. Stuffy or runny nose  
  10. Unusual tiredness or weakness 

Less Common 

  1. Blindness   
  2. Bloody eye   
  3. Blurred or decreased vision   
  4. Change in color vision   
  5. Color changes in the skin around the eyes   
  6. Difficulty seeing at night   
  7. Disturbed color perception   
  8. Double vision   
  9. Dry eyes   
  10. Eye color changes.
  11. Fever or chills   
  12. Halos around lights   
  13. Lack or loss of strength   
  14. Loss of vision   
  15. Night blindness   
  16. Overbright appearance of lights   
  17. Redness, burning, dry, or itching eyes   
  18. Redness, pain, swelling of the eye, eyelid, or inner lining of the eyelid   
  19. Tunnel vision 

How BrandName works 

This medication works in 2 ways: Dorzolamide blocks the carbonic anhydrase enzyme responsible, resulting in low fluid production in the eye. Timolol is a beta‑blocker that reduces how much fluid the eye makes by calming the signals that normally tell it to produce the fluids. 

Safety Measures and Warning 

Pregnancy

BrandName eye drops are safe for use in pregnancy

Breastfeeding

BrandName eye drops are safe for use in breastfeeding

Kidney and Liver Patients

BrandName eye drops are safe for use in kidney and liver problems because they do not interact with eyes. 

BrandName Interaction with Food Product 

Avoid consuming alcohol and smoking simultaneously, as it may affect the drug’s action and show an effect on the brain, leading to severe drowsiness, sedation, and coma in severe cases.

BrandName Interaction with Other Medicines  

Avoid taking BrandName with the following medicines, as it may increase or decrease the desired effect, or in worse cases, it could be fatal:

BrandName Chemical Structure

IUPAC (International Union of Pure and Applied Chemistry)/ Chemical name

Dorzolamide- (4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide

Timolol- (2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol

Intake routine/cycle

Daily dose

Take BrandName exactly as your doctor recommends. The dose may change based on your condition and how well you respond. Do not take more than prescribed without consulting your doctor.

Missed Dose

If you forget to take your medicine, take the medication as soon as you remember. If it’s nearly time for your next dose, skip the missed one and continue with your regular schedule. Always consult the doctor before making any changes to your dosage.

Overdose

It is not recommended to take more than 1000 mg of BrandName per day, as it may cause severe overdosing effects like extreme drowsiness, confusion, unconsciousness, sweating, double vision, low blood pressure, and slurred speech. Immediately seek medical attention and meet the doctor if necessary.

Storage

  1. Store the medicine at room temperature. 
  2. Keep away from sunlight and moisture. 
  3. Keep out of reach of children. 

Directions for use 

  1. Take BrandName exactly as prescribed by your doctor, at the same time each day. 
  2. Do not stop taking BrandName without your doctor’s approval, even if you feel better. 
  3. If you forget to take BrandName, take it as soon as you remember. If it’s almost time for your next dose, skip the missed dose. 

BrandName Summary 

BrandName is a carbonic anhydrase inhibitor used for reducing pressure on eyes in glaucoma and high blood pressure in the eyes. It works by blocking carbonic anhydrase to reduce fluid and pressure. Common side effects are tingling in hands/feet, frequent urination, nausea, fatigue, and electrolyte imbalance. Taking this medicine with high-dose aspirin or alcohol can cause serious side effects like unconsciousness and vomiting. People with severe kidney/liver disease, sulfa allergy, or electrolyte problems should not take it. Overdose occurs after taking more than 1000 mg per day and may cause confusion, drowsiness, severe electrolyte loss, rapid breathing, and coma.

FAQ’s

What are the uses of BrandName tablets?

BrandName tablets are used to lower eye pressure in glaucoma, prevent altitude sickness, and treat high blood pressure in eyes or certain types of epilepsy. They work by reducing excess fluid buildup and balancing pressure in the body.

What are the side effects of BrandName drops?

BrandName tablets can cause common side effects like tingling in hands/feet, frequent urination, nausea, and fatigue; serious risks include electrolyte imbalance, kidney stones, skin reactions, and confusion, so medical monitoring is essential.

What is the drug class of BrandName?

BrandName belong to the drug class of carbonic anhydrase inhibitors and beta blockers.

What are BrandName interactions with other drugs?

BrandName interacts with many drugs, especially diuretics, aspirin, lithium, and seizure medicines; these interactions can increase risks like electrolyte imbalance, toxicity, or reduced drug effectiveness, so it should only be combined under medical supervision.

Reference 

  1. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. Repaglinide. [Updated 2023 Jul 24]. Available from. 
  2. National Center for Biotechnology Information. PubChem Compound Summary for CID 528237, Dorzolamide. Bethesda (MD): National Library of Medicine (US); [updated 2025 Jan 25]. Available from. 
  3. Mayo Clinic. Dorzolamide (ophthalmic route). Rochester (MN): Mayo Foundation for Medical Education and Research; [updated 2025 Apr 30; cited 2026 Feb 2]. Available from. 
  4. Drugs.com. Dorzolamide ophthalmic. [Internet]. Drugs.com; [updated 2025 Jan 15; cited 2026 Feb 2]. Available from. 
  5. WebMD. Dorzolamide ophthalmic. [Internet]. WebMD LLC; [updated 2025 Jan 10; cited 2026 Feb 2]. Available from. 
  6. National Center for Biotechnology Information. PubChem Compound Summary for CID 5281037, Betimol. Bethesda (MD): National Library of Medicine (US); [updated 2024 Dec 12; cited 2026 Jan 30]. Available from. 
  7. Drugs.com. Timolol ophthalmic: Uses, Side Effects & Warnings [Internet]. Drugs.com; 2025 Sep 29 [cited 2026 Jan 30]. Available from. 
  8. National Center for Biotechnology Information. Timolol. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012 [updated 2019 Mar 28; cited 2026 Jan 30]. Available from. 
  9. Mayo Clinic. Timolol (ophthalmic route): Description and Proper Use [Internet]. Rochester (MN): Mayo Foundation for Medical Education and Research; [cited 2026 Jan 30]. Available from. 

Authors

  • Siva Krishna Adithya Bhumireddy completed a Bachelor of Pharmacy from GIET School of Pharmacy, affiliated with Andhra University, and from his 3rd year of graduation, he was working as a freelance medical and publication writer. Having expertise in systematic reviews and clinical research. With his keen interest and skills in research and documentation practices, he also reviewed more than 150 manuscripts from international journals like Elsevier, Springer Nature, and Sage Journals, and all the manuscripts were indexed and appeared in PubMed, Scopus, and Web of Science databases, and he received honorary recognition letters and certificates from all of them. Siva Krishna Adithya also published a few systematic, narrative reviews and a few chapters of international expertise.

    View all posts
  • Mahak Phartyal

    Mahak Phartyal completed her bachelor's in pharmacy from Veer Madho Singh Bhandari Uttarakhand Technical University. She previously worked as a Medical Writer at Meril Life Sciences, where she wrote numerous scientific abstracts for conferences such as India Live 2024 and the European Society of Cardiology (ESC). During her college years, she developed a keen research interest and published an article titled “Preliminary Phytochemical Screening, Physicochemical and Fluorescence Analysis of Nyctanthes arbor-tristis and Syzygium cumini Leaves.

    View all posts

Leave a Reply

Your email address will not be published. Required fields are marked *